NewsBur
No Result
View All Result
Saturday, January 16, 2021
  • Home
  • Morning News
  • Market News
  • Analyst Actions
  • Trending Stocks
Subscribe
Newsbur
  • Home
  • Morning News
  • Market News
  • Analyst Actions
  • Trending Stocks
No Result
View All Result
Newsbur
No Result
View All Result
Home Trending Stocks

Intra-Cellular Therapies Inc. (ITCI)’s stock up by 3.13% As Wednesday Market closes. Is it going higher soon?

by Timothy Webb
July 9, 2020
in Trending Stocks
0
0
SHARES
30
VIEWS
Share on FacebookShare on Twitter

Intra-Cellular Therapies Inc. (NASDAQ:ITCI) went up by 3.13% during the previous trading session, and it is maintaining the win ahead of Wednesday’s trading session. The share price of the Biotechnology giant went up by $25.05 to trade ended Wednesday trading at $24.29. This is up from the $24.29 price recorded on Tuesday’s trading session. Thanks to this latest performance, ITCI is closer to the higher price 52-week target of $70.00 and further from the lowest price target of $32.00. Its performance from the start of the year has also been negative, with ITCI down by -26.99% year-to-date.

Intra-Cellular Therapies Inc. (ITCI) started the day trading at $24.55 and recorded an intraday high of $25.3. It also recorded an intraday low of $24.39 during Wednesday’s trading session. Intra-Cellular Therapies Inc. is a very active stock that recorded a trading volume that is less than -42.25% of the average daily trading volume on Wednesday. The stock’s trading volume on Wednesday was 612378, which is less than -42.25 of the total average daily trading volume of 871.08K.

Intra-Cellular Therapies Inc. (NASDAQ:ITCI) 2020 Performance Impressive

The increase in ITCI’s stock price on Wednesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of ITCI currently stands at $43.56, which is higher than the current trading price of the stock by 42.49%. However, ITCI’s current trading price is -271.11% lower than the 52-week low price of $6.75. In terms of trading volume, Intra-Cellular Therapies Inc. currently experienced healthy participation during the last trading session. 612378 shares of Intra-Cellular Therapies Inc. were traded on the stock exchange on Wednesday, which is less than -42.25% of the 871.08K average trading volume of the stock.

The performance of the stock has been positive over the past year. ITCI’s performance over the past one year has seen it surge by 120.12%, while the stock has gone down by -19.19% in the last six months. The quarterly performance of ITCI currently stands at 63.83%, and it is up by 11.98% in the last month. The only negative figure was from the weekly performance, which currently reads -2.42%. At the time of writing ITCI’s report, the company has a total market cap of $1.73B, making it one of the largest publicly-traded companies in the world.Intra-Cellular Therapies Inc. also has over 330 employees all over the world.

ITCI Insider Activities

For Intra-Cellular Therapies Inc., insiders hold 79.40% of all company shares. The insider transactions over the past six months are down by -0.60%. During that period, insiders bought 92,672 shares in 14 transactions. In that same period, insiders sold 87,340 of their shares in 7 transactions. After these transactions, insiders at Intra-Cellular Therapies Inc. now hold 4.03M shares, which is over 69.59% of the total company stocks. Institutional investors currently hold a large chunk of the ITCI shares, as they control 6.07% of the company’s total stock.

ITCI Fundamental Analysis

For Intra-Cellular Therapies Inc., the stock’s diluted earnings per share (EPS) stands at -2.77. In the coming year, analysts expect the EPS to be -2.69. The stock’s EPS growth this year is 5.60%, -20.10% in the previous five years. In terms of revenue, Intra-Cellular Therapies Inc.’s quarterly sales (YOY) is shrinking at -0.91, which is higher than the average annual revenue of -20.10% over the past half a decade.

The gross margin of the company is 93.90%.

ITCI Analysts Prediction

Another analyst that has a Buy rating for ITCI is Canaccord Genuity, which set a price target of between $29 and $65.

Three analysts, JP Morgan, Cantor Fitzgerald, and Piper Jaffray, all rate the stock as overweight.

ITCI Technical Analysis

The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of ITCI currently stands at 4.64%, while the SMA50 is 14.45%. The biggest one is the SMA200, which is currently reading 41.41% ahead of Wednesday’s trading session. The Relative Strength Index of this stock is 57.77.

Tags: Intra-Cellular Therapies Inc.ITCIITCI stockNASDAQ:ITCI

Recommended Stories

With a Market Cap of $2.79 billion, Here is Why We Love eXp World Holdings Inc. [EXPI]

September 29, 2020

Buy or Sell on Appian Corporation [APPN] as the Price Moves to $62.53?

September 30, 2020

After-Hours Trading Alert: vTv Therapeutics Inc. [VTVT] is Up 5.51% After the Bell

September 23, 2020

Popular Stories

  • Sorrento Therapeutics Inc. [SRNE] is One of the Best Plays in Healthcare and This Proves It

    0 shares
    Share 0 Tweet 0
  • Heat Biologics Inc. [HTBX] is One of the Best Plays in Healthcare and This Proves It

    0 shares
    Share 0 Tweet 0
  • Heat Biologics Inc. [HTBX] Is Skyrocketing 13.15% on Pure Fundamentals

    0 shares
    Share 0 Tweet 0
  • BlackBerry Limited [BB] is a Top Ten Buy with Quarterly Revenues of 999.00M

    0 shares
    Share 0 Tweet 0
  • Impressive Profit Margins of -5.80% Raise Bull Flags for General Electric Company [GE]

    0 shares
    Share 0 Tweet 0

NewsBur.com

Newsbur.com is an Economic news website, which offers broad information about the Stock markets and Equities. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis.

Recent Posts

  • After-Hours Trading Alert: Amgen Inc. [AMGN] is Up 0.85% After the Bell
  • Has Dynatrace Inc. [DT] Completely Outpaced Other Companies in the Technology This Year?
  • Why Applied Materials Inc. [AMAT]’s 1.55% Drop is No Cause for Alarm

Categories

  • Analyst Actions
  • Market News
  • Morning News
  • Trending Stocks
  • Uncategorized

© 2020 Copyright © All Rights Reserved.

No Result
View All Result
  • Home
  • Market News
  • Morning News
  • Analyst Actions
  • Trending Stocks

© 2020 Copyright © All Rights Reserved.